Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review

Adipose-derived stem cells comprise several clinically beneficial qualities that have been explored in basic research and have motivated several clinical studies with promising results. After being approved in the European Union, UK, Switzerland, Israel, and Japan, allogeneic adipose-derived stem ce...

Full description

Bibliographic Details
Main Authors: Tihomir Georgiev-Hristov, Mariano García-Arranz, Jacobo Trébol-López, Paula Barba-Recreo, Damián García-Olmo
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/11/2338
_version_ 1827645771641520128
author Tihomir Georgiev-Hristov
Mariano García-Arranz
Jacobo Trébol-López
Paula Barba-Recreo
Damián García-Olmo
author_facet Tihomir Georgiev-Hristov
Mariano García-Arranz
Jacobo Trébol-López
Paula Barba-Recreo
Damián García-Olmo
author_sort Tihomir Georgiev-Hristov
collection DOAJ
description Adipose-derived stem cells comprise several clinically beneficial qualities that have been explored in basic research and have motivated several clinical studies with promising results. After being approved in the European Union, UK, Switzerland, Israel, and Japan, allogeneic adipose-derived stem cells (darvadstrocel) have been recently granted a regenerative medicine advanced therapy (RMAT) designation by US FDA for complex perianal fistulas in adults with Crohn’s disease. This huge scientific step is likely to impact the future spread of the indications of allogeneic adipose-derived stem cell applications. The current knowledge on adipose stem cell harvest describes quantitative and qualitative differences that could be influenced by different donor conditions and donor sites. In this comprehensive review, we summarize the current knowledge on the topic and propose donor profiles that could provide the optimal initial quality of this living drug, as a starting point for further applications and studies in different pathological conditions.
first_indexed 2024-03-09T18:44:52Z
format Article
id doaj.art-3ec9069af4d44a13974457c273066b59
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T18:44:52Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-3ec9069af4d44a13974457c273066b592023-11-24T06:20:36ZengMDPI AGPharmaceutics1999-49232022-10-011411233810.3390/pharmaceutics14112338Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive ReviewTihomir Georgiev-Hristov0Mariano García-Arranz1Jacobo Trébol-López2Paula Barba-Recreo3Damián García-Olmo4Servicio de Cirugía General y del Aparato Digestivo, Hospital General Universitario de Villalba, 28400 Madrid, SpainInstituto de Investigación Sanitaria, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, SpainServicio de Cirugía General y del Aparato Digestivo, Complejo Asistencial Universitario de Salamanca, 37007 Salamanca, SpainFacultad de Medicina, Universidad Alfonso X, 28691 Madrid, SpainInstituto de Investigación Sanitaria, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, SpainAdipose-derived stem cells comprise several clinically beneficial qualities that have been explored in basic research and have motivated several clinical studies with promising results. After being approved in the European Union, UK, Switzerland, Israel, and Japan, allogeneic adipose-derived stem cells (darvadstrocel) have been recently granted a regenerative medicine advanced therapy (RMAT) designation by US FDA for complex perianal fistulas in adults with Crohn’s disease. This huge scientific step is likely to impact the future spread of the indications of allogeneic adipose-derived stem cell applications. The current knowledge on adipose stem cell harvest describes quantitative and qualitative differences that could be influenced by different donor conditions and donor sites. In this comprehensive review, we summarize the current knowledge on the topic and propose donor profiles that could provide the optimal initial quality of this living drug, as a starting point for further applications and studies in different pathological conditions.https://www.mdpi.com/1999-4923/14/11/2338adipose-derived stem cellsstem cell donorallogenic stem cells
spellingShingle Tihomir Georgiev-Hristov
Mariano García-Arranz
Jacobo Trébol-López
Paula Barba-Recreo
Damián García-Olmo
Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
Pharmaceutics
adipose-derived stem cells
stem cell donor
allogenic stem cells
title Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
title_full Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
title_fullStr Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
title_full_unstemmed Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
title_short Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
title_sort searching for the optimal donor for allogenic adipose derived stem cells a comprehensive review
topic adipose-derived stem cells
stem cell donor
allogenic stem cells
url https://www.mdpi.com/1999-4923/14/11/2338
work_keys_str_mv AT tihomirgeorgievhristov searchingfortheoptimaldonorforallogenicadiposederivedstemcellsacomprehensivereview
AT marianogarciaarranz searchingfortheoptimaldonorforallogenicadiposederivedstemcellsacomprehensivereview
AT jacobotrebollopez searchingfortheoptimaldonorforallogenicadiposederivedstemcellsacomprehensivereview
AT paulabarbarecreo searchingfortheoptimaldonorforallogenicadiposederivedstemcellsacomprehensivereview
AT damiangarciaolmo searchingfortheoptimaldonorforallogenicadiposederivedstemcellsacomprehensivereview